Ron

PALCUS announces honorees for Leadership Awards

WASHINGTON — An internationally known cancer researcher, the first female superintendent of the Rhode Island State Police, a champion for world language education and a relentless immigrant advocate are among those who will recognized at the 22nd Annual Portuguese-American Leadership Council of the United States (PALCUS) Awards Gala. “This year, as in years past, our […]

PALCUS announces honorees for Leadership Awards Read More »

Genetics and Biology of Prostate Cancer

Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer remains largely incurable even after intensive multimodal therapy. The lethality of advanced disease is driven by the lack of therapeutic regimens capable of generating durable responses in the setting of extreme tumor heterogeneity on the genetic and cell biological levels. Here, we review

Genetics and Biology of Prostate Cancer Read More »

HPV vaccination rates show progress, but off track for 2020 goal

In 2006, a safe and effective human papillomavirus (HPV) vaccine became available to protect against cancers caused by HPV infection. HPV vaccination rates in adolescent boys and girls are rising, though still not fast enough, with HPV-linked cancer cases soaring by nearly 45% between 1999 and 2015. Fewer than half of American adolescents have been

HPV vaccination rates show progress, but off track for 2020 goal Read More »

HPV-related cancer rates are rising. So are vaccine rates — just not fast enough

Cancers linked to the human papillomavirus have increased significantly over the last 15 years in the United States, with throat cancer now the most common HPV-related malignancy, the Centers for Disease Control and Prevention reported Thursday. More than 43,000 people developed HPV-associated cancer in 2015, compared with about 30,000 in 1999, the CDC said. At

HPV-related cancer rates are rising. So are vaccine rates — just not fast enough Read More »

An update on the Prostate Cancer Moon Shot’s efforts to improve outcomes, save lives

Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the American Cancer Society, more than 160,000 new cases will be diagnosed in the country this year, and more than 29,000 will die from the disease. MD Anderson’s Prostate Cancer Moon Shot™ was founded to improve

An update on the Prostate Cancer Moon Shot’s efforts to improve outcomes, save lives Read More »

Get Insights From Ron

Sign up for the latest news and updates from Ron DePinho, MD